Skip to Content

Vaccines, Volume 12, Issue 1

2024 January - 108 articles

Cover Story: The DNA (deoxyribonucleic acid) vaccine, a gene vaccine, works by harnessing host cell machinery to produce a peptide antigen capable of generating an immune response leading to the development of durable immunity. The development requires the sequencing of a target antigen gene. The gene is synthesized and loaded into a vector, commonly either a bacterial plasmid or a viral vector. The vector system can be further engineered by adding specific molecules to enhance cellular uptake and nuclear translocation. The site and route of delivery are chosen according to targeted cell populations and immunostimulatory features. The host cell’s native machinery transcribes and translates the delivered DNA and generates an antigen product, which is then presented to immune cells. The result is a robust innate and subsequent adaptive immune response leading to the formation of immunological memory. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (108)

  • Article
  • Open Access
1 Citations
4,305 Views
17 Pages

Comparative Evaluation of Recombinant and Acellular Pertussis Vaccines in a Murine Model

  • Kyu-Ri Kang,
  • Ji-Ahn Kim,
  • Gyu-Won Cho,
  • Han-Ul Kang,
  • Hyun-Mi Kang,
  • Jin-Han Kang,
  • Baik-Lin Seong and
  • Soo-Young Lee

22 January 2024

Since the 2000s, sporadic outbreaks of whooping cough have been reported in advanced countries, where the acellular pertussis vaccination rate is relatively high, and in developing countries. Small-scale whooping cough has also continued in many coun...

  • Article
  • Open Access
11 Citations
7,594 Views
13 Pages

Suboptimal MMR Vaccination Coverages—A Constant Challenge for Measles Elimination in Romania

  • Aurora Stanescu,
  • Simona Maria Ruta,
  • Costin Cernescu and
  • Adriana Pistol

22 January 2024

Measles is targeted for elimination since 2001, with a significant reduction in cases recorded worldwide, but outbreaks occur periodically due to immunization gaps. This study analyzes the evolution of vaccination coverage rates (VCRs) in Romania, a...

  • Article
  • Open Access
6 Citations
2,935 Views
17 Pages

Effects of G and SH Truncation on the Replication, Virulence, and Immunogenicity of Avian Metapneumovirus

  • Seung-Min Hong,
  • Eun-Jin Ha,
  • Ho-Won Kim,
  • Seung-Ji Kim,
  • Sun-Min Ahn,
  • Se-Hee An,
  • Gun Kim,
  • Suji Kim,
  • Hyuk-Joon Kwon and
  • Kang-Seuk Choi

21 January 2024

Four mutants varying the length of the G and SH genes, including a G-truncated mutant (ΔG) and three G/SH-truncated mutants (ΔSH/G-1, ΔSH/G-2, and ΔSH/G-3), were generated via serially passaging the avian metapneumovirus strai...

  • Brief Report
  • Open Access
3 Citations
2,990 Views
11 Pages

Immunity to Tick-Borne Encephalitis Virus NS3 Protein Induced with a Recombinant Modified Vaccinia Virus Ankara Fails to Afford Mice Protection against TBEV Infection

  • Mareike Kubinski,
  • Jana Beicht,
  • Thomas Gerlach,
  • Amare Aregay,
  • Albert D. M. E. Osterhaus,
  • Alina Tscherne,
  • Gerd Sutter,
  • Chittappen Kandiyil Prajeeth and
  • Guus F. Rimmelzwaan

20 January 2024

Tick-borne encephalitis (TBE) is a serious neurological disease caused by TBE virus (TBEV). Because antiviral treatment options are not available, vaccination is the key prophylactic measure against TBEV infections. Despite the availability of effect...

  • Article
  • Open Access
1 Citations
3,349 Views
22 Pages

Association of the Magnitude of Anti-SARS-CoV-2 Vaccine Side Effects with Sex, Allergy History, Chronic Diseases, Medication Intake, and SARS-CoV-2 Infection

  • Elias A. Said,
  • Afnan Al-Rubkhi,
  • Sanjay Jaju,
  • Crystal Y. Koh,
  • Mohammed S. Al-Balushi,
  • Khalid Al-Naamani,
  • Siham Al-Sinani,
  • Juma Z. Al-Busaidi and
  • Ali A. Al-Jabri

20 January 2024

Vaccination provides the best protection against the increasing infections of SARS-CoV-2. The magnitude and type of anti-SARS-CoV-2 vaccine side effects (SEs) depend on parameters that are not fully understood. In this cross-sectional study, the asso...

  • Article
  • Open Access
6 Citations
3,836 Views
16 Pages

Host Genetic Variation Impacts SARS-CoV-2 Vaccination Response in the Diversity Outbred Mouse Population

  • Marta C. Cruz Cisneros,
  • Elizabeth J. Anderson,
  • Brea K. Hampton,
  • Breantié Parotti,
  • Sanjay Sarkar,
  • Sharon Taft-Benz,
  • Timothy A. Bell,
  • Matthew Blanchard,
  • Jacob A. Dillard and
  • Martin T. Ferris
  • + 10 authors

20 January 2024

The COVID-19 pandemic led to the rapid and worldwide development of highly effective vaccines against SARS-CoV-2. However, there is significant individual-to-individual variation in vaccine efficacy due to factors including viral variants, host age,...

  • Systematic Review
  • Open Access
3 Citations
4,710 Views
14 Pages

19 January 2024

During the coronavirus diseases 2019 (COVID-19) pandemic, the safety and efficacy of vaccination during pregnancy, particularly regarding the risk of preterm birth, have been a subject of concern. This systematic review aims to evaluate the impact of...

  • Article
  • Open Access
2,793 Views
12 Pages

Toxoplasma gondii eIF-5A Modulates the Immune Response of Murine Macrophages In Vitro

  • Xinchao Liu,
  • Xiaoyu Li,
  • Chunjing Li,
  • Mingmin Lu,
  • Lixin Xu,
  • Ruofeng Yan,
  • Xiaokai Song and
  • Xiangrui Li

19 January 2024

Toxoplasma gondii (T. gondii) is an obligate intracellular protozoan that can elicit a robust immune response during infection. Macrophage cells have been shown to play an important role in the immune response against T. gondii. In our previous study...

  • Article
  • Open Access
3 Citations
2,955 Views
19 Pages

Safety and Immunogenicity of the Convacell® Recombinant N Protein COVID-19 Vaccine

  • Sevastyan Rabdano,
  • Ellina Ruzanova,
  • Denis Makarov,
  • Anastasiya Vertyachikh,
  • Valeriya Teplykh,
  • German Rudakov,
  • Iuliia Pletyukhina,
  • Nikita Saveliev,
  • Konstantin Zakharov and
  • Veronika Skvortsova
  • + 3 authors

19 January 2024

We have developed Convacell®—a COVID-19 vaccine based on the recombinant nucleocapsid (N) protein of SARS-CoV-2. This paper details Convacell’s® combined phase I/II and IIb randomized, double-blind, interventional clinical trials....

  • Article
  • Open Access
21 Citations
7,168 Views
13 Pages

Prevalence and Factors Associated with Long COVID Symptoms among U.S. Adults, 2022

  • Kimberly H. Nguyen,
  • Yingjun Bao,
  • Julie Mortazavi,
  • Jennifer D. Allen,
  • Patricia O. Chocano-Bedoya and
  • Laura Corlin

18 January 2024

Long COVID and its symptoms have not been examined in different subpopulations of U.S. adults. Using the 2022 BRFSS (n = 445,132), we assessed long COVID and each symptom by sociodemographic characteristics and health-related variables. Multivariable...

  • Communication
  • Open Access
1 Citations
2,093 Views
7 Pages

18 January 2024

With the worldwide spread of SARS-CoV-2 disease, people with cystic fibrosis (CF), especially solid organ transplant recipients, have quickly been identified as a risk group for severe disease. Studies have shown low antibody response to SARS-CoV-2 v...

  • Review
  • Open Access
21 Citations
19,590 Views
27 Pages

18 January 2024

Respiratory Syncytial Virus (RSV) poses a significant global health concern as a major cause of lower respiratory tract infections (LRTIs). Over the last few years, substantial efforts have been directed towards developing vaccines and therapeutics t...

  • Article
  • Open Access
2 Citations
5,699 Views
15 Pages

18 January 2024

In North America, range constraints due to burgeoning development increasingly encroach on wild horse habitat and necessitate effective but humane reproductive management. The largest free-roaming wild horse fertility control program by population (&...

  • Article
  • Open Access
6 Citations
3,374 Views
24 Pages

Development of Cross-Reactive Live Attenuated Influenza Vaccine Candidates against Both Lineages of Influenza B Virus

  • Pei-Fong Wong,
  • Irina Isakova-Sivak,
  • Ekaterina Stepanova,
  • Elena Krutikova,
  • Ekaterina Bazhenova,
  • Andrey Rekstin and
  • Larisa Rudenko

18 January 2024

Background: Influenza viruses continue to cause a significant social and economic burden globally. Vaccination is recognized as the most effective measure to control influenza. Live attenuated influenza vaccines (LAIVs) are an effective means of prev...

  • Brief Report
  • Open Access
5 Citations
2,044 Views
10 Pages

Measuring Variant-Specific Neutralizing Antibody Profiles after Bivalent SARS-CoV-2 Vaccinations Using a Multivariant Surrogate Virus Neutralization Microarray

  • David Niklas Springer,
  • Eva Höltl,
  • Katja Prüger,
  • Elisabeth Puchhammer-Stöckl,
  • Judith Helene Aberle,
  • Karin Stiasny and
  • Lukas Weseslindtner

18 January 2024

The capability of antibodies to neutralize different SARS-CoV-2 variants varies among individuals depending on the previous exposure to wild-type or Omicron-specific immunogens by mono- or bivalent vaccinations or infections. Such profiles of neutral...

  • Article
  • Open Access
3 Citations
2,788 Views
11 Pages

Factors Associated with the Implementation of Pediatric Immunization Services: A Survey of Community Pharmacies

  • Oluchukwu M. Ezeala,
  • Nicholas P. McCormick,
  • Christopher L. Meininger,
  • Spencer H. Durham,
  • Tessa J. Hastings and
  • Salisa C. Westrick

18 January 2024

Pharmacists are well-positioned to help increase pediatric immunization rates. This study assessed the types of pediatric vaccines offered in community pharmacies, compared participant/pharmacy characteristics and participants’ perceptions of b...

  • Article
  • Open Access
3 Citations
4,154 Views
13 Pages

Harnessing Pentameric Scaffold of Cholera Toxin B (CTB) for Design of Subvirion Recombinant Dengue Virus Vaccine

  • Jemin Sung,
  • Yucheol Cheong,
  • Young-Seok Kim,
  • Jina Ahn,
  • Myung Hyun Sohn,
  • Sanguine Byun and
  • Baik-Lin Seong

17 January 2024

Dengue virus is an enveloped virus with an icosahedral assembly of envelope proteins (E). The E proteins are arranged as a head-to-tail homodimer, and domain III (EDIII) is placed at the edge of the dimer, converging to a pentamer interface. For a st...

  • Article
  • Open Access
2 Citations
2,400 Views
16 Pages

Differences in Responses of Immunosuppressed Kidney Transplant Patients to Moderna mRNA-1273 versus Pfizer-BioNTech

  • Dulat Bekbolsynov,
  • Andrew Waack,
  • Camryn Buskey,
  • Shalmali Bhadkamkar,
  • Keegan Rengel,
  • Winnifer Petersen,
  • Mary Lee Brown,
  • Tanaya Sparkle,
  • Dinkar Kaw and
  • Stanislaw Stepkowski
  • + 6 authors

17 January 2024

Immunosuppressed kidney transplant (KT) recipients produce a weaker response to COVID-19 vaccination than immunocompetent individuals. We tested antiviral IgG response in 99 KT recipients and 66 healthy volunteers who were vaccinated with mRNA-1273 M...

  • Brief Report
  • Open Access
2,068 Views
9 Pages

Endemic Human Coronavirus-Specific Nasal Immunoglobulin A and Serum Immunoglobulin G Dynamics in Lower Respiratory Tract Infections

  • Ferdyansyah Sechan,
  • Katherine Loens,
  • Herman Goossens,
  • Margareta Ieven and
  • Lia van der Hoek

17 January 2024

Endemic human coronaviruses (HCoV) NL63, 229E, OC43, and HKU1 cause respiratory infection. Following infection, a virus-specific serum antibody rise is usually observed, coinciding with recovery. In some cases, an infection is not accompanied by an i...

  • Article
  • Open Access
7 Citations
5,512 Views
15 Pages

A Holistic Strategy of Mother and Child Health Care to Improve the Coverage of Routine and Polio Immunization in Pakistan: Results from a Demonstration Project

  • Muhammad Atif Habib,
  • Sajid Bashir Soofi,
  • Zamir Hussain,
  • Imran Ahmed,
  • Rehman Tahir,
  • Saeed Anwar,
  • Ahmed Ali Nauman,
  • Muhammad Sharif,
  • Muhammad Islam and
  • Zulfiqar A. Bhutta
  • + 1 author

16 January 2024

Background: The eradication of poliovirus and improving routine immunization (RI) coverage rates present significant challenges in Pakistan. There is a need for interventions that focus on strengthening community engagement to improve routine immuniz...

  • Article
  • Open Access
1 Citations
2,751 Views
20 Pages

A Potential Association between Abdominal Obesity and the Efficacy of Humoral Immunity Induced by COVID-19 and by the AZD1222, Convidecia, BNT162b2, Sputnik V, and CoronaVac Vaccines

  • Javier Angeles-Martinez,
  • Irma Eloisa Monroy-Muñoz,
  • José Esteban Muñoz-Medina,
  • Larissa Fernandes-Matano,
  • Ángel Gustavo Salas-Lais,
  • Ma De Los Ángeles Hernández-Cueto,
  • Eyerahi Bravo-Flores,
  • Moisés León-Juárez,
  • Clara Esperanza Santacruz-Tinoco and
  • Daniel Montes-Herrera

15 January 2024

Abdominal obesity is highly prevalent in Mexico and has a poor prognosis in terms of the severity of coronavirus disease (COVID-19) and low levels of antibodies induced by infection and vaccination. We evaluated the humoral immune response induced by...

  • Review
  • Open Access
19 Citations
4,697 Views
16 Pages

15 January 2024

Among emergent climate-sensitive infectious diseases, some mosquito-vectored arbovirus infections have epidemiological, social, and economic effects. Dengue virus (DENV), West Nile virus (WNV), and Chikungunya virus (CHIKV) disease, previously common...

  • Article
  • Open Access
1,818 Views
12 Pages

Analysis of CVC1302-Mediated Enhancement of Monocyte Recruitment in Inducing Immune Responses

  • Haiyan Lu,
  • Xiaoming Yu,
  • Liting Hou,
  • Yuanpeng Zhang,
  • Lan Li,
  • Xuwen Qiao,
  • Haiwei Cheng,
  • Luping Du,
  • Jin Chen and
  • Jibo Hou
  • + 1 author

15 January 2024

Monocytes (Mos) are believed to play important roles during the generation of immune response. In our previous study, CVC1302, a complex of PRRs agonists, was demonstrated to recruit Mo into lymph nodes (LNs) in order to present antigen and secret ch...

  • Article
  • Open Access
3,205 Views
12 Pages

The Risk of Herpes Zoster Events in Patients with Spondyloarthritis and the Effect of BNT162b2 mRNA COVID-19 Vaccine

  • Tal Gazitt,
  • Noa Hayat,
  • Nili Stein,
  • Amir Haddad,
  • Ilan Feldhamer,
  • Arnon Dov Cohen,
  • Walid Saliba and
  • Devy Zisman

15 January 2024

The data on the risk of herpes zoster (HZ) in spondyloarthropathy (SpA) patients are sparse, especially regarding its association with the novel mRNA COVID-19 vaccines and immunosuppressants. We aimed to evaluate whether SpA diagnosis and/or immunosu...

  • Article
  • Open Access
12 Citations
6,156 Views
12 Pages

13 January 2024

Human papillomavirus (HPV) vaccine uptake among adolescent girls is critical to reducing the burden of HPV-related cancers in Nigeria. This study assesses the factors influencing caregivers’ acceptance of HPV vaccination for their charges, usin...

  • Article
  • Open Access
7 Citations
4,784 Views
20 Pages

Burden and Impact of Reactogenicity among Adults Receiving COVID-19 Vaccines in the United States and Canada: Results from a Prospective Observational Study

  • Matthew D. Rousculp,
  • Kelly Hollis,
  • Ryan Ziemiecki,
  • Dawn Odom,
  • Anthony M. Marchese,
  • Mitra Montazeri,
  • Shardul Odak,
  • Laurin Jackson,
  • Angela Miller and
  • Seth Toback

13 January 2024

As SARS-CoV-2 variants continue to emerge, vaccination remains a critical tool to reduce the COVID-19 burden. Vaccine reactogenicity and the impact on work productivity/daily activities are recognized as contributing factors to vaccine hesitancy. To...

  • Review
  • Open Access
9 Citations
8,994 Views
14 Pages

13 January 2024

The growing use of biological drugs in immune-mediated chronic diseases has undoubtedly revolutionized their treatment. Yet, the topic of vaccinations in this group of patients still raises many concerns and implies many therapeutic problems that req...

  • Article
  • Open Access
2 Citations
2,392 Views
25 Pages

12 January 2024

Since late 2019, most efforts to control the COVID-19 pandemic have focused on developing vaccines. By mid-2020, some vaccines fulfilled international regulations for their application. However, these vaccines have shown a decline in effectiveness se...

  • Article
  • Open Access
9 Citations
4,354 Views
18 Pages

Exploring Perceptions and Practices Regarding Adult Vaccination against Seasonal Influenza, Tetanus, Pneumococcal Disease, Herpes Zoster and COVID-19: A Mixed-Methods Study in Greece

  • Iordanis Avramidis,
  • Ilias Pagkozidis,
  • Philippe-Richard J. Domeyer,
  • Georgios Papazisis,
  • Ilias Tirodimos,
  • Theodoros Dardavesis and
  • Zoi Tsimtsiou

12 January 2024

We aimed to document vaccination coverage for five vaccines, predictors of each vaccine’s uptake and attitudes regarding adult vaccination. Adults visiting four pharmacies were randomly invited to participate during summer 2022. Among 395 parti...

  • Article
  • Open Access
7 Citations
3,763 Views
22 Pages

The Development of a Rabies Virus-Vectored Vaccine against Borrelia burgdorferi, Targeting BBI39

  • Shantel Rios,
  • Bibek Bhattachan,
  • Kruthi Vavilikolanu,
  • Chrysoula Kitsou,
  • Utpal Pal and
  • Matthias J. Schnell

12 January 2024

Lyme disease (LD) is the most common tick-borne illness in the United States (U.S.), Europe, and Asia. Borrelia burgdorferi, a spirochete bacterium transmitted by the tick vector Ixodes scapularis, causes LD in the U.S. If untreated, Lyme arthritis,...

  • Article
  • Open Access
2 Citations
2,972 Views
13 Pages

A Mixture of T-Cell Epitope Peptides Derived from Human Respiratory Syncytial Virus F Protein Conferred Protection in DR1-TCR Tg Mice

  • Hong Guo,
  • Yang Song,
  • Hai Li,
  • Hongqiao Hu,
  • Yuqing Shi,
  • Jie Jiang,
  • Jinyuan Guo,
  • Lei Cao,
  • Naiying Mao and
  • Yan Zhang

12 January 2024

Human respiratory syncytial virus (HRSV) poses a significant disease burden on global health. To date, two vaccines that primarily induce humoral immunity to prevent HRSV infection have been approved, whereas vaccines that primarily induce T-cell imm...

  • Article
  • Open Access
1 Citations
2,077 Views
10 Pages

12 January 2024

Only a few studies have been carried out on the efficacy and safety of a fourth dose of the COVID-19 vaccine in patients with cancer. In this prospective observational study, we aimed to assess the serological response and safety of the fourth booste...

  • Article
  • Open Access
15 Citations
2,435 Views
10 Pages

Coverage with the First Dose of Human Papillomavirus Vaccination among Females Aged 9–50 Years in Shenzhen, China: A Surveillance Based on Administrative Health Records in 2023

  • Zian Lin,
  • Xue Liang,
  • Lixian Su,
  • Weijun Peng,
  • Hongbiao Chen,
  • Yuan Fang,
  • Siyu Chen,
  • Weikang Yang,
  • Wensheng Chen and
  • Zixin Wang
  • + 1 author

12 January 2024

China started to offer human papillomavirus (HPV) vaccines to females aged 9–45 years in 2016. However, there was a lack of reports about HPV vaccination coverage in a representative sample of females in China. Therefore, this study aimed to ex...

  • Article
  • Open Access
4 Citations
3,421 Views
16 Pages

Going Forward: Potential Impact of Protein-Based COVID-19 Vaccination Coverage on Population Outcomes and Costs in the United States

  • Kyle Paret,
  • Hadi Beyhaghi,
  • William L. Herring,
  • Josephine Mauskopf,
  • Lesley G. Shane and
  • Matthew D. Rousculp

12 January 2024

Policymakers in the United States (US) recommend coronavirus disease 2019 (COVID-19) vaccination with a monovalent 2023–2024 vaccine formulation based on the Omicron XBB.1.5 variant. We estimated the potential US population-level health and eco...

  • Article
  • Open Access
2 Citations
3,940 Views
17 Pages

Immunogenicity of Intradermal Versus Intramuscular BNT162b2 COVID-19 Booster Vaccine in Patients with Immune-Mediated Dermatologic Diseases: A Non-Inferiority Randomized Controlled Trial

  • Chutima Seree-aphinan,
  • Ploysyne Rattanakaemakorn,
  • Poonkiat Suchonwanit,
  • Kunlawat Thadanipon,
  • Yanisa Ratanapokasatit,
  • Tanat Yongpisarn,
  • Kumthorn Malathum,
  • Pornchai Simaroj,
  • Chavachol Setthaudom and
  • Kumutnart Chanprapaph
  • + 2 authors

11 January 2024

The intradermal route has emerged as a dose-sparing alternative during the coronavirus disease 2019 (COVID-19) pandemic. Despite its efficacy in healthy populations, its immunogenicity has not been tested in immune-mediated dermatologic disease (IMDD...

  • Article
  • Open Access
7 Citations
3,511 Views
22 Pages

Differences in the Evolution of Clinical, Biochemical, and Hematological Indicators in Hospitalized Patients with COVID-19 According to Their Vaccination Scheme: A Cohort Study in One of the World’s Highest Hospital Mortality Populations

  • Martha A. Mendoza-Hernandez,
  • Jose Guzman-Esquivel,
  • Marco A. Ramos-Rojas,
  • Vanessa V. Santillan-Luna,
  • Carmen A. Sanchez-Ramirez,
  • Gustavo A. Hernandez-Fuentes,
  • Janet Diaz-Martinez,
  • Valery Melnikov,
  • Fabian Rojas-Larios and
  • Ivan Delgado-Enciso
  • + 5 authors

11 January 2024

COVID-19 vaccines primarily prevent severe illnesses or hospitalization, but there is limited data on their impact during hospitalization for seriously ill patients. In a Mexican cohort with high COVID-19 mortality, a study assessed vaccination&rsquo...

  • Review
  • Open Access
59 Citations
17,346 Views
23 Pages

11 January 2024

The concept of DNA vaccination was introduced in the early 1990s. Since then, advancements in the augmentation of the immunogenicity of DNA vaccines have brought this technology to the market, especially in veterinary medicine, to prevent many diseas...

  • Article
  • Open Access
2 Citations
2,993 Views
20 Pages

Haemato-Immunological Response of Immunized Atlantic Salmon (Salmo salar) to Moritella viscosa Challenge and Antigens

  • Maryam Ghasemieshkaftaki,
  • Trung Cao,
  • Ahmed Hossain,
  • Ignacio Vasquez and
  • Javier Santander

10 January 2024

Winter ulcer disease is a health issue in the Atlantic salmonid aquaculture industry, mainly caused by Moritella viscosa. Although vaccination is one of the effective ways to prevent bacterial outbreaks in the salmon farming industry, ulcer disease r...

  • Article
  • Open Access
1 Citations
3,147 Views
13 Pages

No Waning of Pneumococcal Vaccine Responses over Time in People with Inflammatory Arthritis: Findings from a Single Centre Cohort

  • Deepak Nagra,
  • Katie Bechman,
  • Mark D. Russell,
  • Zijing Yang,
  • Maryam Adas,
  • Sujith Subesinghe,
  • Andrew Rutherford,
  • Edward Alveyn,
  • Samir Patel and
  • James Galloway
  • + 6 authors

10 January 2024

Background: Vaccination against pneumococcus reduces the risk of infective events, hospitalisation, and death in individual with inflammatory arthritis, particularly in those on immunomodulating therapy who are at risk of worse outcomes from pneumoco...

  • Editorial
  • Open Access
1 Citations
2,013 Views
3 Pages

Special Issue: Vaccines against Antibiotic-Resistant Bacteria: From Bench to Bedside

  • Mireia López-Siles,
  • Andrés Corral-Lugo and
  • Michael J. McConnell

9 January 2024

The emergence and global dissemination of bacterial strains from numerous species with resistance to multiple antibiotic classes has increased in recent years, both in the healthcare and the community setting [...]

  • Article
  • Open Access
8 Citations
3,158 Views
16 Pages

A Recombinant Multivalent Vaccine (rCpa1) Induces Protection for C57BL/6 and HLA Transgenic Mice against Pulmonary Infection with Both Species of Coccidioides

  • Althea Campuzano,
  • Komali Devi Pentakota,
  • Yu-Rou Liao,
  • Hao Zhang,
  • Nathan P. Wiederhold,
  • Gary R. Ostroff and
  • Chiung-Yu Hung

9 January 2024

Coccidioidomycosis is caused by Coccidioides posadasii (Cp) and Coccidioides immitis (Ci), which have a 4–5% difference in their genomic sequences. There is an urgent need to develop a human vaccine against both species. A previously created re...

  • Article
  • Open Access
2 Citations
5,661 Views
12 Pages

Safety of Immunization for Children with Immune Thrombocytopenia

  • Xiangshi Wang,
  • Tianxing Feng,
  • Chuning Wang,
  • Jingjing Li,
  • Yanling Ge,
  • Xiaowen Zhai,
  • Hongsheng Wang and
  • Mei Zeng

9 January 2024

Vaccine hesitancy is a common issue for children with immune thrombocytopenia (ITP) in China. The objective of this paper is to assess the immunization statuses of children with ITP, analyze the possible relationship between immunization and thromboc...

  • Article
  • Open Access
9 Citations
6,578 Views
14 Pages

Screening and Stability Evaluation of Freeze-Dried Protective Agents for a Live Recombinant Pseudorabies Virus Vaccine

  • Yan Liu,
  • Suling Zhang,
  • Shuai Wang,
  • Chunhui Zhang,
  • Xiaorui Su,
  • Linghua Guo,
  • Xiaofei Bai,
  • Yuxin Huang,
  • Wenqiang Pang and
  • Kegong Tian
  • + 1 author

9 January 2024

Infection of pigs with the pseudorabies virus (PRV) causes significant economic losses in the pig industry. Immunization with live vaccines is a crucial aspect in the prevention of pseudorabies in swine. The TK/gE/gI/11k/28k deleted pseudorabies vacc...

  • Article
  • Open Access
2 Citations
2,756 Views
12 Pages

Evaluation of a Vaccine Candidate Designed for Broad-Spectrum Protection against Type A Foot-and-Mouth Disease in Asia

  • Sung Ho Shin,
  • Seong Yun Hwang,
  • Hyun-Mi Kim,
  • Se Hee Shin,
  • Mi-Kyeong Ko,
  • Min Ja Lee,
  • Su-Mi Kim and
  • Jong-Hyeon Park

9 January 2024

Foot-and-mouth disease (FMD) vaccines are currently the most powerful protective and preventive measures used to control FMD. In this study, the chimeric vaccine strain containing antigenic epitopes from the FMD virus serotype A, which belongs to the...

  • Article
  • Open Access
11 Citations
11,535 Views
17 Pages

8 January 2024

Colorectal cancer (CRC) currently ranks as the third most common cancer in the United States, and its incidence is on the rise, especially among younger individuals. Despite the remarkable success of immune checkpoint inhibitors (ICIs) in various can...

  • Case Report
  • Open Access
3 Citations
3,452 Views
10 Pages

Tip Lesion Most Frequent FSGS Variant Related to COVID-19 Vaccine: Two Case Reports and Literature Review

  • Emmy Marjorie Carvalho de Araújo,
  • Marcos Adriano Garcia Campos,
  • Andressa Monteiro Sodré,
  • Maria Izabel de Holanda,
  • Rodrigo Hagemann,
  • Antonio Augusto Lima Teixeira Júnior,
  • Natalino Salgado Filho,
  • Precil Diego Miranda de Menezes Neves and
  • Gyl Eanes Barros Silva

8 January 2024

Large-scale COVID-19 vaccination has been one of the most effective strategies to control the spread of the SARS-CoV-2 virus. However, several cases of glomerular injury related to the COVID-19 vaccine have been described in the literature. We report...

  • Perspective
  • Open Access
3 Citations
4,732 Views
15 Pages

8 January 2024

The use of mRNA-based immunotherapies that leverage the genomes of oncolytic viruses holds significant promise in addressing glioblastoma (GBM), an exceptionally aggressive neurological tumor. We explore the significance of mRNA-based platforms in th...

  • Article
  • Open Access
4 Citations
4,177 Views
12 Pages

The Immunogenicity of CpG, MF59-like, and Alum Adjuvant Delta Strain Inactivated SARS-CoV-2 Vaccines in Mice

  • Kangwei Xu,
  • Jing Li,
  • Xu Lu,
  • Xiaoqin Ge,
  • Kaiqin Wang,
  • Jiahao Wang,
  • Zhizhong Qiao,
  • Yaru Quan and
  • Changgui Li

7 January 2024

The continuous evolution and mutation of SARS-CoV-2 have highlighted the need for more effective vaccines. In this study, CpG, MF59-like, and Alum adjuvant Delta strain inactivated SARS-CoV-2 vaccines were prepared, and the immunogenicity of these va...

  • Article
  • Open Access
1 Citations
2,965 Views
13 Pages

COVID-19 Antibody Levels among Various Vaccination Groups, One-Year Antibody Follow-Up in Two University Hospitals from Western and Central Turkey

  • Mehmet Soylu,
  • Pınar Sağıroğlu,
  • Muhammed Alper Özarslan,
  • Oğuzhan Acet,
  • Zeynep Türe Yüce,
  • Feyza İzci Çetinkaya,
  • Seyfi Durmaz,
  • Ömür Mustafa Parkan,
  • Deniz Akyol and
  • Memnune Selda Erensoy
  • + 10 authors

7 January 2024

Various clinical outcomes, reinfections, vaccination programs, and antibody responses resulted from the COVID-19 pandemic. This study investigated the time-dependent changes in SARS-CoV-2 antibody responses in infected and/or vaccinated and unvaccina...

of 3

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X